203 related articles for article (PubMed ID: 18292688)
21. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
Resmini E; Minuto F; Colao A; Ferone D
Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
[TBL] [Abstract][Full Text] [Related]
22. Metabolic syndrome and the menopause.
Kaaja RJ
Menopause Int; 2008 Mar; 14(1):21-5. PubMed ID: 18380957
[TBL] [Abstract][Full Text] [Related]
23. [Pathophysiology of impaired insulin sensitivity in the perioperative period].
Assmann A; Spranger J
Anasthesiol Intensivmed Notfallmed Schmerzther; 2011 Apr; 46(4):250-5; quiz 256. PubMed ID: 21484620
[TBL] [Abstract][Full Text] [Related]
24. Metabolic syndrome: at the crossroads of cardiorenal risk.
Natali A; Pucci G; Boldrini B; Schillaci G
J Nephrol; 2009; 22(1):29-38. PubMed ID: 19229816
[TBL] [Abstract][Full Text] [Related]
25. Perioperative glycemic control: an evidence-based review.
Lipshutz AK; Gropper MA
Anesthesiology; 2009 Feb; 110(2):408-21. PubMed ID: 19194167
[TBL] [Abstract][Full Text] [Related]
26. Clinical study of the risk factors of insulin resistance and metabolic syndrome after kidney transplantation.
Sui W; Zou H; Zou G; Yan Q; Chen H; Che W; Xie S
Transpl Immunol; 2008 Nov; 20(1-2):95-8. PubMed ID: 18703143
[TBL] [Abstract][Full Text] [Related]
27. Niacin in the metabolic syndrome: more risk than benefit?
Ginsberg HN
Nat Clin Pract Endocrinol Metab; 2006 Jun; 2(6):300-1. PubMed ID: 16932303
[No Abstract] [Full Text] [Related]
28. Comorbidities in polycystic ovary syndrome: their relationship to insulin resistance.
Bethea SW; Nestler JE
Panminerva Med; 2008 Dec; 50(4):295-304. PubMed ID: 19078870
[TBL] [Abstract][Full Text] [Related]
29. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk.
Després JP; Lemieux I; Bergeron J; Pibarot P; Mathieu P; Larose E; Rodés-Cabau J; Bertrand OF; Poirier P
Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1039-49. PubMed ID: 18356555
[TBL] [Abstract][Full Text] [Related]
30. Exercise-induced alterations in muscle lipid metabolism improve insulin sensitivity.
Horowitz JF
Exerc Sport Sci Rev; 2007 Oct; 35(4):192-6. PubMed ID: 17921788
[TBL] [Abstract][Full Text] [Related]
31. Mechanisms of hypertension in the cardiometabolic syndrome.
Redon J; Cifkova R; Laurent S; Nilsson P; Narkiewicz K; Erdine S; Mancia G
J Hypertens; 2009 Mar; 27(3):441-51. PubMed ID: 19262221
[TBL] [Abstract][Full Text] [Related]
32. The metabolic syndrome: a gathering challenge in a time of abundance.
Bricker LA; Greydanus DE
Adolesc Med State Art Rev; 2008 Dec; 19(3):475-97, ix. PubMed ID: 19227387
[TBL] [Abstract][Full Text] [Related]
33. Effects of combined olmesartan and pravastatin on glucose intolerance and cardiovascular remodeling in a metabolic-syndrome model.
Mizukawa M; Ohmori K; Obayashi A; Ishihara Y; Yoshida J; Noma T; Yukiiri K; Kosaka H; Kohno M
Hypertens Res; 2009 Jul; 32(7):617-24. PubMed ID: 19461650
[TBL] [Abstract][Full Text] [Related]
34. Hypoglycemic pharmacological treatment of type 2 diabetes: targeting the endothelium.
Nathanson D; Nyström T
Mol Cell Endocrinol; 2009 Jan; 297(1-2):112-26. PubMed ID: 19038307
[TBL] [Abstract][Full Text] [Related]
35. Management of metabolic syndrome: statins.
Xydakis AM; Ballantyne CM
Endocrinol Metab Clin North Am; 2004 Sep; 33(3):509-23, vi. PubMed ID: 15262294
[TBL] [Abstract][Full Text] [Related]
36. Metabolic implications of dietary trans-fatty acids.
Dorfman SE; Laurent D; Gounarides JS; Li X; Mullarkey TL; Rocheford EC; Sari-Sarraf F; Hirsch EA; Hughes TE; Commerford SR
Obesity (Silver Spring); 2009 Jun; 17(6):1200-7. PubMed ID: 19584878
[TBL] [Abstract][Full Text] [Related]
37. Changes in insulin resistance and cardiovascular risk induced by PPARgamma activation have no impact on RBP4 plasma concentrations in nondiabetic patients.
Pfützner A; Schöndorf T; Hanefeld M; Lübben G; Kann PH; Karagiannis E; Wilhelm B; Forst T
Horm Metab Res; 2009 Mar; 41(3):202-6. PubMed ID: 19224430
[TBL] [Abstract][Full Text] [Related]
38. Pair feeding-mediated changes in metabolism: stress response and pathophysiology in insulin-resistant, atherosclerosis-prone JCR:LA-cp rats.
Russell JC; Proctor SD; Kelly SE; Brindley DN
Am J Physiol Endocrinol Metab; 2008 Jun; 294(6):E1078-87. PubMed ID: 18413677
[TBL] [Abstract][Full Text] [Related]
39. Glycemic control and prevention of perioperative infection.
Blondet JJ; Beilman GJ
Curr Opin Crit Care; 2007 Aug; 13(4):421-7. PubMed ID: 17599013
[TBL] [Abstract][Full Text] [Related]
40. Insulin resistance and metabolic syndrome in chronic liver diseases: old entities with new implications.
Tsochatzis EA; Manolakopoulos S; Papatheodoridis GV; Archimandritis AJ
Scand J Gastroenterol; 2009; 44(1):6-14. PubMed ID: 18661429
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
